JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fanning, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fanning, G. L.
Anesth Analg 2001;92:560
© 2001 International Anesthesia Research Society


LETTERS

Hyaluronidase in Ophthalmic Anesthesia

Gary L. Fanning, MD

Hauser-Ross Eye Institute Sycamore, IL

To the Editor:

Kallio et al. (1) have shown that a commonly used concentration of hyaluronidase (7.5 U/mL) is at least twice that required to produce an acceptable orbital block. I wish they had used an even smaller concentration in their study. For several years, using a block technique similar to theirs, I have had a 95% incidence of >95% akinesia using no more than 1–1.5 U/mL.

The success of an orbital block is influenced more by the anatomical location of the injectate than by the use of hyaluronidase. Nonetheless, using it helps to disperse the injectate, improves the block, and reduces the incidence of posterior vitreal pressure associated with a bolus of solution sitting behind the globe. As evidenced by the rash of extraocular muscle dysfunctions reported during a recent hyaluronidase shortage (2,3), using hyaluronidase also prevented myotoxicity in these delicate muscles, although the mechanism has yet to be explained.

All who perform orbital regional anesthesia should heed the message that 7.5 U/mL is much more hyaluronidase than is necessary to achieve a good block. Using small concentrations will save a lot of money in a busy ophthalmic practice.

References

  1. Kallio H, Paloheimo M, Maunuksela E-L. Hyaluronidase as an adjuvant in bupivacaine-lidocaine mixture for retrobulbar/peribulbar block. Anesth Analg 2000; 91: 934–7.[Abstract/Free Full Text]
  2. Brown SM, Brooks SE, Mazow ML, et al. Cluster of diplopia cases after periocular anesthesia without hyaluronidase. J Cataract Refract Surg 1999; 25: 1245–9.[Web of Science][Medline]
  3. Troll G, Borodic G. Diplopia after cataract surgery using 4% lidocaine in the absence of Wydase (sodium hyaluronidase) [letter]. J Clin Anesth 1999; 11: 615–6.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fanning, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fanning, G. L.


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2001 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press